Determinants of Drug Response in Severe Chronic Heart Failure. 1. Activation of Vasoconstrictor Forces During Vasodilator Therapy

Circulation - United States
doi 10.1161/01.cir.64.3.506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pharmacoeconomic Analysis of Chronic Heart Failure Drug Therapy in Patients With Comorbid Conditions

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2018English

Oral Vasodilator Protocol Among Advanced Decompensated Heart Failure Patients Managed With Intravenous Vasodilator Therapy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Pcv47 - Pharmacoeconomic Analysis of Chronic Heart Failure Drug Therapy in Patients With Comorbid Conditions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Biomarker Guided Therapy in Chronic Heart Failure

Cardiac Failure Review
2015English

Progress in Gene Therapy for Chronic Heart Failure

Heart Surgery Forum
SurgeryCardiovascular MedicineCardiology
2018English

Ventilation Response During Physical Testing in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease

Biomedical Journal of Scientific & Technical Research
2019English

Patient With Chronic Heart Failure. Rational Choice of Therapy

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2017English

Peculiarities of Therapy for Heart Rhythm Disorders in Patients With Chronic Heart Failure

Kardiologiya
Cardiovascular MedicineCardiology
2017English

Modern Chronic Heart Failure Therapy in Context of Pulmonary Banding to Avoid Heart Transplantation

Molecular and Cellular Pediatrics
Child HealthPediatricsPerinatologyMolecular BiologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy